Line 24 Quiz

Create an informative and engaging illustration depicting various diabetic medications and cardiovascular drugs, with a clear focus on their mechanisms of action and indications, set in a clinical environment.

Diabetes and Cardiovascular Pharmacotherapy Quiz

Test your knowledge on diabetes management and cardiovascular pharmacotherapy with our comprehensive quiz! This quiz includes 45 carefully crafted questions that cover various aspects of drug indications, mechanisms of action, and clinical applications.

Explore the latest treatment guidelines.
Challenge your understanding of medication mechanisms.
Boost your pharmacological knowledge!

45 Questions11 MinutesCreated by LearningDoctor752

In diabetic patients; to consider monotherapy with Metformin , patient HbA1c must be

Less than 9%

More than 9%

9 - 10 %

Mechanism of action of Andorivaban

Direct factor Xa inhibitor

Indirect factor Xa inhibitor

Prevent thrombin formation

Prevent platelet aggregation

Andouristat tablets are scored

True

False

Protectopril plus is

Cardio protective

Decrease incidence of stroke

Both 1 and 2

Record trial compared Rivaroxban with Low molecular weight heparin (Enoxparin)

True

False

Andouristat differ from other Febouxstat in double aluminium packaging

True

False

Protectopril is Perindopril Arginine while Coversyl is Perindopril Erbumine

True

False

Andoglycemic 1000 mg can be taken as

Once daily

Twice daily

Two tablets as one shot in case of 2 gm

Twice daily in case of 2 gm

Andorivaban should be stopped before surgery by

12 hours

72 hours

24 - 48 hours

Andouristat mechanism of action

Xanthine Oxidase Inhibitor

Xanthine dehydrogenase inhibitor

Both 1 and 2

Indication of Protectopril

Mild hypertension

Mild to moderate hypertension

Severe hypertension

Andoglycemic 1000 mg monthly cost is

24 L.E

60 L.E

36 L.E

Andorivaban 2.5 class in ESC 2019 is

IIa

IIb

Andouristat act on 5 Enzymes , while Allopurinol act on 1 Enzyme

True

False

Main Competitor for Protectopril is Coversyl and it's price 90 L.E

True

False

FDA approved Indication of Andoglycemic

Prediabetic

Type II diabetes

Type 1 diabetes

Losing weight

Indication of Andorivaban 2.5 is

Chronic coronary arterial disease

Acute coronary arterial disease

Chronic peripheral arterial disease

Acute peripheral arterial disease

Andouristat has a linear pharmacokinetics from 10 - 240 mg

True

False

Protectopril is an ACE inhibitor

True

False

Andoglycemic main competitor is Glucophage XR and it's monthly cost is 60 L.E

True

False

Andouristat dose is 80 mg taken twice daily and may be increased to 120 mg after 1 month

True

False

Protectopril 8 mg is scored

True

False

Protectopril dose is taken

Once daily

Twice daily

Once or Twice

Protectopril plus is Perindopril with

Indapamide

Hydrochlorothiazide

Calcium channel blocker

Indication of Andorivaban 10 mg in Orthopedics

Total hip replacement

Total Knee replacment

Immobilized patients

Which drug is more tolerable ?

Glucophage intermediate release

Cidophage Retard

Andoglycemic extended release

Andorivaban 10 mg price is 152 L.E , while Andorivaban 2.5 mg monthly cost is 180 L.E

True

False

Protectopril price is 44 L.E , while Protectopril plus price is 32 L.E

True

False

Target Serum uric acid

Less 6%

6 - 7 %

More than 8%

Andouristat 80 mg price is 56 L.E , while Andouristat 120 mg price is 62 L.E

True

False

To consider dual therapy for diabetic patients , HbA1c should be

Less than 9%

9% - 10%

More than 10 %

Normal HbA1c level

Less than 5.7 %

5.7 % - 6.4 %

More than 10 %

Spacing between Andorivaban and NSAIDs should be

2 - 3 hours

4 - 6 hours

6 - 8 hours

Andoglycemic XR affect which parameter

FPG and PPG

HOMA - IR

HbA1c

All the above

Duration of Andorivaban in patients with Total hip replacement is 5 week , while Total knee replacement 2 week

True

False

Fasting Plasma Glucose (FPG) normal is

Less than 100 mg/dl

100 - 125 mg/dl

More than 125 mg/dl

Perfect age to use Andorivaban 2.5 mg

Less than 45 years

45 - 65 years

More than 65 years

Prediabetic Post prandial Plasma Glucose (PPG) level is

Less than 140 mg/dl

140 - 180 mg/dl

More than 180 mg/dl

The Result of Record 1 79 % RRR in total VTE , while Record 2 70%

True

False

In Compass trial MI decreased by 14 % while major CVS events decreased by 24%

True

False

In hazard trial Heart disease increase by

2.5 fold

3 fold

3.6 fold

8.5 fold

In compass trial stroke decreased without any significant bleeding by RRR

42%

28%

44%

24%

In Record trial Andorivaban shows lower risk in bleeding than Enoxparin

True

False

In Compass trial; the acute limb ischemic attacks decreases amputation by 77%

True

False

In hazard trial; the liver disease increase by 8.5 folds

True

False

Line 24 Quiz

Diabetes and Cardiovascular Pharmacotherapy Quiz

More Surveys